Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05. (Q43102323)
Jump to navigation
Jump to search
scientific article published on 12 April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05. |
scientific article published on 12 April 2010 |
Statements
1 reference
Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05. (English)
1 reference
1 reference
1 reference
1 reference
Jean Mendiboure
1 reference
Marine Castaing
1 reference
Michel Barrois
1 reference
David Malka
1 reference
Olivier Bouché
1 reference
Delphine Le Corre
1 reference
Isabelle Miran
1 reference
Claire Mulot
1 reference
Michel Ducreux
1 reference
12 April 2010
1 reference
1 reference
28
1 reference
15
1 reference
2556-2564
1 reference
Identifiers
1 reference
1 reference